Detecting Colorectal Cancer With Liver Metastatic Lesions Using Novel Precise Imaging Tools

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Liver Metastasis Colon Cancer
Interventions
DRUG

18-PSMA

Intravenous push 4 MBq/kg per patient (for a 70 kg patient, 280 MBq of \[18F\]FPSMA needs to be intravenously injected), and the maximum dose cannot exceed 400 MBq. After the injection of \[18F\]FPSMA, intravenous flushing was performed with 20 ml of normal saline.

Sponsors
All Listed Sponsors
collaborator

Kaohsiung Chang Gung Memorial Hospital,Taiwan

UNKNOWN

lead

Primo Biotechnology Co., Ltd

INDUSTRY